Serum Levels of Carbamylated LDL, Nitrotyrosine and Soluble Lectin-like Oxidized Low-density Lipoprotein Receptor-1 in Poorly Controlled Type 2 Diabetes Mellitus

Teodora R. Stankova; Ginka T. Delcheva; Ana I. Maneva; Stefka V. Vladeva

doi:10.3897/folmed.61.e39343

Original Article

Folia Medica 61(3): 419-425
https://doi.org/10.3897/folmed.61.e39343 (30 Sep 2019)

Other versions:

(Verbatim name)

(Catalog Number)

DES

Invalid DOI was provided, please try again

(9)

(0)

Amina M. Alieva, Irina E. Baykova, Elena V. Reznik, Natalia V. Teplova, Ramiz K. Valiev, Malika Kh. Gyzyeva, Albina B. Sultangalieva, Irina A. Kotikova, Natalia A. Novikova, Sergey A. Korvyakov, Igor G. Nikitin (2024)
LOX-1 as a biological marker and therapeutic target in cardiovascular pathology (literature review). Consilium Medicum 26: 666.

DOI: 10.26442/20751753.2024.10.202945

Wui Fang Chai, Kim San Tang (2021)
Protective potential of cerium oxide nanoparticles in diabetes mellitus. Journal of Trace Elements in Medicine and Biology 66: 126742.

DOI: 10.1016/j.jtemb.2021.126742

Hui-Yuan Zhang, Xi Lu, Yue-Han Hao, Ling Tang, Zhi-Yi He (2022)
Oxidized low-density lipoprotein receptor 1: a novel potential therapeutic target for intracerebral hemorrhage. Neural Regeneration Research 17: 1795.

DOI: 10.4103/1673-5374.332157

Kohzo Takebayashi, Tatsuhiko Suzuki, Mototaka Yamauchi, Kenji Hara, Takafumi Tsuchiya, Toshihiko Inukai, Koshi Hashimoto (2021)
Association of circulating soluble lectin-like oxidized low-density lipoprotein receptor-1 with inflammatory markers and urinary albumin excretion in patients with type 2 diabetes. SAGE Open Medicine 9: .

DOI: 10.1177/20503121211064468

Grzegorz K. Jakubiak, Grzegorz Cieślar, Agata Stanek (2022)
Nitrotyrosine, Nitrated Lipoproteins, and Cardiovascular Dysfunction in Patients with Type 2 Diabetes: What Do We Know and What Remains to Be Explained?. Antioxidants 11: 856.

DOI: 10.3390/antiox11050856

Renuka Ramalingam Manoharan, Ankush Prasad, Pavel Pospíšil, Julia Kzhyshkowska (2024)
ROS signaling in innate immunity via oxidative protein modifications. Frontiers in Immunology 15: .

DOI: 10.3389/fimmu.2024.1359600

Teodora Stankova, Ginka Delcheva, Ana Maneva, Stefka Vladeva (2019)
Serum Levels of Carbamylated LDL and Soluble Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Are Associated with Coronary Artery Disease in Patients with Metabolic Syndrome. Medicina 55: 493.

DOI: 10.3390/medicina55080493

Richard Kehm, Tim Baldensperger, Jana Raupbach, Annika Höhn (2021)
Protein oxidation - Formation mechanisms, detection and relevance as biomarkers in human diseases. Redox Biology 42: 101901.

DOI: 10.1016/j.redox.2021.101901

Damien Denimal (2023)
Carbamylated lipoproteins in diabetes. World Journal of Diabetes 14: 159.

DOI: 10.4239/wjd.v14.i3.159

Subscribe to email alerts for current Article's categories